Pseudohypoparathyroidism

[MIM 612 463]

Estimated prevalence of 0.3 to 1.1 /100,000. Heterogeneous group of diseases caused by insensitivity to parathyroid hormone, leading to renal and/or bone abnormalities.


From a genetic point of view, several types are identified:



The GNAS gene encodes the stimulating alpha subunit (Gs), an intracellular G protein that stimulates the production of cAMP in response to certain physiological stimuli.


Clinical presentation:

In childhood, hypocalcemia can lead to crises of tetany, muscle cramps or seizures. Later: muscle weakness, bone pain.


Comparative table:


Name

phenotype

PTH rate

vit D

CA

phosphates

Erythrocyte gs

hypoparathyroidism

normal

low

low

low

high

normal

pseudo hypopara 1A

dysplasia

high

low

low

high

diminished

pseudo hypopara 1B

normal

high

low

low

high

normal

pseudo hypopara 1C

dysplasia

high

low

low

high

normal

pseudohypopara 2

normal

high

low

low

high

normal

pseudopseudo hypoparathyroidism

dysplasia

normal

normal

normal

normal

normal


Treatment: supplements of calcium and vitamin D and phosphate chelators by mouth.


Anesthetic implications:

check calcemia, avoid hyperventilation. Make sure that there are no other associated endocrine abnormalities (types Ia and Ic)


References : 

-        Kahloul N, Chaari W, Boughamoura L, Charfeddine L, Khammeri S, Amri F. 
Un syndrome de Fahr révélateur d’une pseudohypoparathyroïdie. 
Arch Pédiatr 2009 ; 16 :444-8.


Updated: May 2022